Monocytosis
Last updated: 8 September 2026
Reviewed by: Specialist doctors from the quality team at Elfcare
Persistent fatigue, unexplained weight loss, or night sweats can be signs of monocytosis. So can a routine blood test coming back with an elevated white blood cell count and a doctor noting that monocyte levels are higher than normal. Monocytosis, an elevation in circulating monocytes, most commonly reflects the immune system responding to infection or inflammation, but in a clinically important minority of cases it signals an underlying haematological condition needing specialist assessment.
Monocytosis is frequently discovered incidentally during a routine blood test. Understanding its cause is the most important clinical step after identifying it, as the underlying condition determines both the significance of the finding and the appropriate response.
Book a consultation now to test health
What is monocytosis?
Monocytosis means you have a higher-than-normal number of monocytes in your blood. Monocytes are a type of white blood cell that help fight infection, remove damaged cells, and support tissue repair and immune regulation.
Doctors divide a high monocyte count into two main types based on what is causing it:
Reactive monocytosis: this is the most common type. Your body is simply reacting to an outside trigger, like a recent infection, long-term inflammation, or tissue damage, and temporarily making extra cells to help you heal.
Clonal monocytosis: this is rarer and happens when a bone marrow disorder causes your body to pump out abnormal immune cells on its own. The primary cause is a blood cancer called chronic myelomonocytic leukaemia (CMML).
Determining whether monocytosis is reactive or clonal is the most important next step after it has been identified.
Symptoms of monocytosis
Reactive monocytosis rarely causes symptoms beyond those of the underlying condition driving it. Clonal monocytosis from CMML or other haematological conditions may cause:
Persistent fatigue and weakness from anaemia caused by bone marrow crowding
Recurrent or severe infections from impaired neutrophil production
Unexplained weight loss and night sweats
Splenomegaly causing left upper abdominal fullness or discomfort
Easy bruising and bleeding from thrombocytopenia
Skin infiltration with monocytic cells in CMML, causing plaques or nodules
Mild reactive monocytosis typically causes no specific symptoms beyond those of the triggering condition.
What causes monocytosis?
The causes differ significantly between reactive and clonal forms.
Reactive monocytosis:
Chronic infections tuberculosis, subacute bacterial endocarditis, brucellosis, and some fungal infections can cause sustained monocytosis
Recovery from acute infection monocyte counts commonly rise temporarily as the bone marrow recovers after some infections
Inflammatory conditions inflammatory bowel disease, rheumatoid arthritis, lupus, sarcoidosis, and vasculitis can cause persistent monocytosis
Malignancy some solid tumours and lymphomas are associated with reactive monocytosis
Post-splenectomy removal of the spleen eliminates a major site of monocyte clearance, causing sustained elevation
Recovery from bone marrow suppression chemotherapy or severe illness causing bone marrow suppression is followed by monocytosis as part of haematopoietic recovery
Clonal monocytosis:
Chronic myelomonocytic leukaemia (CMML) is the most important primary cause, characterised by persistent monocytosis above 1.0 x 10⁹/L lasting more than three months without an identifiable reactive cause, alongside dysplastic changes in bone marrow cells
Acute monocytic leukaemia is a subtype of acute myeloid leukaemia with predominant monocytic differentiation
Myelodysplastic syndrome can evolve to include monocytosis as part of progressive bone marrow failure
How is monocytosis detected?
Monocytosis is detected directly through a full blood count with differential, with supporting markers helping identify the underlying cause and distinguishing reactive from clonal forms.
Blood tests Elfcare's panel includes monocyte count as part of the full blood count differential, alongside key supporting markers:
Absolute monocyte count: confirms the condition when your count rises above normal limits, showing whether monocytes are the only high cells or if others are involved.
Haemoglobin, platelets, and neutrophils: abnormalities across these multiple blood cell types strongly hint at a bone marrow disorder rather than a normal immune response.
CRP and ferritin: high levels indicate active inflammation or infection, proving your body is simply reacting to an illness.
LDH and uric acid: high levels signal rapid cell turnover, which often points toward blood-related cancers.
Liver function (ALT, AST, ALP): helps assess liver involvement in systemic illness and provides general clinical context.
Vitamin B12 and folate: help identify deficiencies that can affect blood cell production.
Albumin: Low levels reveal long-term nutrition or illness struggles, mapping your body's overall health burden.
Abdominal MRI Elfcare's full body MRI images the spleen and abdominal lymph nodes as part of the standard abdominal sequence. If splenomegaly or enlarged abdominal lymph nodes are present alongside persistent monocytosis, these findings can provide additional clinical context and help guide further specialist assessment. MRI does not diagnose CMML or other blood cancers on its own, but it can identify structural findings that support the overall clinical picture.
Why early detection matters
Reactive monocytosis is important to identify because it almost always signals an underlying condition, most commonly chronic infection or inflammation, that requires its own investigation and management. Chronic infections causing monocytosis, particularly tuberculosis and subacute bacterial endocarditis, are serious conditions that benefit significantly from early identification and treatment. Clonal monocytosis from CMML, if identified early before significant anaemia, infection risk, or transformation to acute leukaemia has occurred, allows for risk stratification and treatment that improves both quality of life and survival. The median age of CMML diagnosis is approximately 70-75 years, and identifying it through a routine blood count before it has caused significant bone marrow failure gives the widest window for therapeutic intervention.
How Elfcare can help
Elfcare's full blood count includes absolute monocyte count and full white cell differential as standard, making monocytosis a directly detectable finding in every health check. Our panel covers CRP, ferritin, LDH, uric acid, liver function, and metabolic markers, providing inflammatory and systemic context that helps interpret monocytosis alongside the full blood count and clinical picture.
Our abdominal MRI provides structural assessment of the spleen and abdominal lymph nodes, adding important context when haematological malignancy is a concern.
If our blood tests or MRI identify monocytosis or related findings requiring further assessment, we take care of further diagnostics or refer you to the appropriate specialist.
Summary
Monocytosis is an elevation in circulating monocytes that most commonly reflects a reactive immune response to chronic infection, inflammation, or tissue damage, and in a clinically important minority signals clonal bone marrow disease including chronic myelomonocytic leukaemia. It is directly detectable through a full blood count, a standard component of Elfcare's blood panel. Our comprehensive panel covers the inflammatory, nutritional, and haematological markers needed to distinguish reactive from clonal causes, while our abdominal MRI provides structural assessment of the spleen and lymph nodes. Early identification of monocytosis and its underlying cause is essential for appropriate management and for protecting long-term haematological and systemic health.
Last updated: 8 September 2026
Reviewed by: Specialist doctors from the quality team at Elfcare
FAQ
-
Monocytosis is an absolute monocyte count above 1.0 x 10⁹/L. Monocytes are the largest circulating white blood cells, playing a central role in innate immunity, pathogen destruction, and inflammatory regulation. Monocytosis is most commonly reactive, reflecting the immune system responding to chronic infection, inflammation, or tissue damage. In a clinically important minority it reflects a clonal bone marrow disorder, most importantly chronic myelomonocytic leukaemia (CMML).
-
Reactive monocytosis causes no specific symptoms beyond those of the underlying condition. Clonal monocytosis from CMML may cause persistent fatigue from anaemia, recurrent infections from impaired neutrophil production, unexplained weight loss and night sweats, splenomegaly causing left upper abdominal fullness, and easy bruising from thrombocytopenia.
-
Reactive causes include chronic infections including tuberculosis and subacute bacterial endocarditis, inflammatory conditions including IBD and rheumatoid arthritis, malignancy, corticosteroid use, post-splenectomy, and bone marrow recovery after suppression. Clonal causes include chronic myelomonocytic leukaemia, acute monocytic leukaemia, and myelodysplastic syndrome.
-
A full blood count with differential measuring absolute monocyte count is the primary detection tool. CRP, ferritin, LDH, uric acid, and liver function help distinguish reactive from clonal causes and identify the underlying driver. Abdominal MRI identifies splenomegaly and lymphadenopathy suggesting haematological malignancy.
-
Yes. Elfcare's full blood count includes absolute monocyte count and full differential as standard. Our panel covers CRP, ferritin, uric acid, liver function, and metabolic markers. Our abdominal MRI provides structural assessment of the spleen and lymph nodes. If monocytosis or related findings are identified, we take care of further diagnostics or refer you to the appropriate specialist.
-
Treatment depends entirely on the underlying cause. Reactive monocytosis resolves when the underlying infection, inflammation, or trigger is treated. CMML is managed according to risk stratification, with lower-risk disease managed supportively and higher-risk disease treated with hypomethylating agents including azacitidine, or allogeneic stem cell transplantation in eligible patients. Early identification of clonal monocytosis and appropriate risk stratification is the most important factor in optimising long-term outcomes.